OCX-063

N/A

Report date: 2025/02/08 15:01:13
NME

Base Information

Drug NameOCX-063
Drug Alias NameOCX-063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsOvarian cancer G-protein coupled receptor 1 inhibitors
TargetsOvarian cancer G-protein coupled receptor 1
Therapy Area/IndicationsDiabetic macular oedemaGlomerulosclerosis, Focal SegmentalMacular Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOccuRx Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCerta Therapeutics Pty LtdOccuRx Pty Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaGlomerulosclerosis, Focal SegmentalMacular Degeneration +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A